Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: An analysis from the clopidogrel for the reduction of events during observation trial

Kristofer Dosh, Peter B. Berger, Steven Marso, Fredrick Van Lente, Danielle M. Brennan, Richard Charnigo, Eric J. Topol, Steven Steinhubl